General requirements.
New Orleans City Code § 82-691
in effectSec. 82-691. - General requirements.
(a) Pooling. Pooling of plasma by the collector or processor of source plasma (human) from two or more donors is not permitted. Two units of plasma from the same donor may be pooled if such units are collected during one plasmapheresis procedure, provided the pooling is done by a procedure that gives maximum assurance of a sterile container of plasma.
(b) Storage. Immediately after filling, the plasma shall be stored at not warmer than minus 20 degrees Celsius, except for plasma collected as provided for in section 82-692.
(c) Inspection. Source plasma (human) shall be inspected at the time of issuance. If there is any evidence of thawing, the unit shall not be issued.
(d) Pilot samples. If pilot samples are provided, they shall meet the following standards:
(1) Prior to filling, all pilot samples shall be marked or identified so as to relate them directly to the donor of that unit of plasma.
(2) All pilot samples shall be filled at the time the final product is prepared by the person who prepares the final product.
(3) All pilot samples shall be representative of the contents of the final product.
(4) All pilot samples shall be collected in a manner that does not contaminate the contents of the final container.
(e) Labeling. In addition to the labeling requirements of federal and state law, the following information shall appear on the label affixed to each container of source plasma (human):
(1) The proper name of the product.
(2) Name, address and license number of the processor.
(3) Donor number.
(4) Collection date of the plasma.
(5) The statement: "Caution: For Processing Use Only".
(6) The statement: "Store at -20° C. or colder".
(7) A statement as to whether the plasma was collected from normal donors or from immunized donors. In the case of immunized donors, the label shall state the immunizing antigen.
(8) The total volume of plasma and total quantity and type of anticoagulant used.
(9) The test for hepatitis B antigen used and the results.
(f) Processing responsibility. All steps in the processing of source plasma (human), including donor examination, blood collection, plasmapheresis, laboratory testing, labeling, storage and issuing shall be performed by the establishment licensed to process source plasma (human), except that the following tests may be performed by a clinical laboratory licensed by a state or federal agency, or by an establishment licensed for blood or blood derivatives under section 351 of the Public Health Service Act, provided such arrangements are approved by the director:
(1) The test for hepatitis B antigen pursuant to section 82-689.
(2) The serum protein electrophoresis or quantitative immunodiffusion test for immunoglobulin as required by section 82-687(1).
(3) Such testing pursuant to subsections (f)(1) and (2) of this section shall not be considered divided processing, requiring two product licenses for source plasma (human), provided that:
a. The results of such tests are maintained by the establishment licensed for source plasma (human) whereby such results may be reviewed by a licensed physician as required in section 82-687(2), and/or by authorized department of health inspectors.
b. The source plasma (human) processor has obtained a written agreement that the testing laboratory will permit authorized department of health inspectors to inspect their testing procedures and facilities during any reasonable business hours.
c. The testing laboratory will participate in any proficiency testing programs undertaken by the department of health.
(g) Records. In addition to the general recordkeeping requirements of section 82-521, every processor of source plasma (human) must keep for each donor a separate and complete record of all initial and periodic examinations, tests, laboratory data, interviews, etc., undertaken pursuant to sections 82-663 and 82-686 through 82-689. This record must also contain the original or a clear copy of the donor's written consent for participation in the plasmapheresis program as required by section 82-661 and the certification of good health as prescribed in section 82-663(b). Each donor record must be directly cross referenced to the unit of source plasma (human) associated with the donor.
(Code 1956, § 29-150)
Source: City of New Orleans, Code of Ordinances and Home Rule Charter (Municode Library, library.municode.com)URL: https://library.municode.com/la/new_orleans/codes/code_of_ordinances?nodeId=PTIICO_CH82HESA_ARTXISTOPBLBAPLCE_DIV9PL_S82-691GEREFetched: 10/28/2026
